Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Dow Fourth Quarter 2025 Earnings Call - Transform to Outperform Targets $2B EBITDA Boost with 4,500 Role Reductions
Dow closed 2025 with a soft fourth quarter, delivering operating EBITDA of $741 million and guiding first quarter EBITDA to roughly $750 million as seasonal demand and targeted margin tailwinds kick i...
- Q4 2025 operating EBITDA was $741 million, down sequentially on seasonality and margin compression.
- Management expects Q1 2026 operating EBITDA of approximately $750 million, reflecting seasonal improvement and cost savings, offset by higher turnaround spending and lower equity earnings.
- Transform to Outperform aims to deliver at least $2 billion of near-term EBITDA uplift, with two thirds from productivity and one third from growth.
- +11 more takeaways
OneWater Marine Fiscal First Quarter 2026 Earnings Call - 110 bps Margin Gain and Asset Sale to Cut Leverage
OneWater reported a quietly constructive Q1, with revenue roughly flat at $381 million, gross margin up 110 basis points to 23.5%, and adjusted EBITDA improving to $4 million. The quarter showed a cle...
- Revenue was essentially flat at $381 million, a 1% increase year over year compared with $376 million in Q1 2025.
- Gross profit rose to $89 million and gross margin expanded by 110 basis points to 23.5%, driven by better new-boat margins, pre-owned strength, and portfolio optimization.
- New boat unit sales declined 6% year over year, while pre-owned boat sales jumped 24%, driven by higher units and higher average selling prices.
- +12 more takeaways
Xerox Holdings Corporation Q4 2025 Earnings Call - Betting on Lexmark and ITsavvy integration to drive >$200M operating income rebound in 2026 amid memory cost shocks
Xerox closed 2025 with headline revenue growth driven by acquisitions, but the underlying business still shows strain. Reported Q4 revenue was $2.03 billion, up roughly 26% (24% cc) thanks to Lexmark ...
- Reported Q4 revenue $2.03 billion, up ~26% year-over-year (24% in constant currency), driven by the Lexmark and ITsavvy acquisitions.
- On a pro forma basis (ex-acquisitions), Q4 revenue declined about 9%; for full-year 2025, pro forma revenue declined ~8% excluding acquisition benefits.
- Adjusted operating income margin was 5.0% in Q4, down 140 basis points year-over-year; full-year adjusted operating margin was 3.5%, also down 140 bps.
- +12 more takeaways
Celestica Q4 2025 Earnings Call - Raising CapEx to $1B to Capture Hyperscaler AI and 1.6T Networking Ramps
Celestica closed 2025 with blowout results, led by an outsized CCS segment. Q4 revenue of $3.65 billion and adjusted EPS of $1.89 beat the high end of guidance, and full-year 2025 revenue of $12.4 bil...
- Q4 2025 results strong: revenue $3.65 billion up 44% year-over-year, adjusted EPS $1.89 up 70%, both above the high end of guidance.
- Full-year 2025: revenue $12.4 billion (+28% Y/Y) and adjusted EPS $6.05 (+56% Y/Y); adjusted operating margin 7.5%, second consecutive year of 100 bps improvement.
- CCS segment drove the quarter: $2.86 billion revenue, up 64%, and represented 78% of company revenue in Q4; both communications and enterprise end markets accelerated.
- +12 more takeaways
1-800-FLOWERS.COM Q2 FY2026 Earnings Call - Marketing Pullback Improves Margins, Costs But Drives Top-Line Decline
Management ran a surgical, sometimes painful, reset in Q2, trading topline growth for a cleaner, more profitable demand model. Operational issues from last year were largely fixed, the org was flatten...
- Consolidated revenue declined 9.5% in Q2 FY2026, reflecting a deliberate pullback in marketing to improve contribution margin.
- Consumer Floral and Gifts segment fell 22.7%, driving most of the top-line weakness; Gourmet Foods and Gift Baskets declined 3.8%, BloomNet declined 3.1%.
- Management intentionally reduced marketing spend to improve ad-to-sales and marketing contribution margin, accepting near-term top-line pressure for longer-term profitability.
- +12 more takeaways
Virtu Financial Q4 2025 Earnings Call - Record NT and 100% Return on Incremental Capital Drive Strong Quarter
Virtu closed 2025 with a clear message, profits and momentum. Q4 adjusted net trading income hit $9.7 million per day, $613 million for the quarter, the highest quarterly NT since Q1 2021, driven by a...
- Adjusted net trading income was $9.7 million per day in Q4 2025, $613 million for the quarter, the highest quarterly NT since Q1 2021.
- Full year 2025 NT averaged $8.6 million per day, totaling $2.1 billion for the year.
- Market Making produced $7.8 million per day in Q4 and $6.7 million per day for full year 2025.
- +12 more takeaways
TAL Education Group Q3 FY2026 Earnings Call - Revenue Up 27%, Margins Jump, Devices Scale but Remain Investment-Heavy
TAL reported a strong Q3 FY2026: revenue of $770.2 million, up 27% year-over-year, with gross margin expanding to 56.1% and non-GAAP operating income of $104.0 million. Core learning services, both of...
- Net revenue $770.2 million in Q3 FY2026, up 27.0% year-over-year in USD (26.8% in RMB).
- Non-GAAP income from operations was $104.0 million; non-GAAP net income attributable to TAL was $141.4 million for the quarter.
- Gross profit rose 35.0% year-over-year to $431.8 million; gross margin improved to 56.1% from 52.7% a year ago.
- +12 more takeaways
Takeda Q3 FY25 Earnings Call - Three Phase 3 Wins and Launch Prep Meet Vyvanse Hit, Guidance Held by Cost Cuts
Takeda reported a mixed quarter. The company confirmed three positive Phase 3 readouts for oveporexin, rusfertide and zasocitinib, has filed NDAs for oveporexin and rusfertide and is preparing regulat...
- Takeda delivered three positive Phase 3 readouts in 2025: oveporexin, rusfertide and zasocitinib, all described as meeting or exceeding expectations.
- NDAs for oveporexin and rusfertide have been submitted to the FDA, and Takeda is awaiting formal acceptance.
- Zasocitinib showed strong phase 3 psoriasis results (fast onset, PASI75 at 4 weeks, >50% PASI90 at week 16, ~30% PASI100), filing prep underway with an expected launch in calendar 2027.
- +15 more takeaways
Lloyds Banking Group FY2025 Earnings Call - Upgraded 2026 RoTE target above 16% as AI and structural hedge drive income and capital returns
Lloyds closed FY2025 showing clear momentum, upgraded guidance, and a bigger appetite for returning capital. Statutory profit after tax was GBP 4.8 billion, net income rose 7% to GBP 18.3 billion, NII...
- Management says strategic delivery is accelerating, upgrading the 2026 return on tangible equity target to greater than 16%.
- FY2025 statutory profit after tax was GBP 4.8 billion, RoTE 12.9%, or 14.8% excluding Q3 motor provision.
- Net income for 2025 was GBP 18.3 billion, up 7% year on year; NII was GBP 13.6 billion, up 6%, and other operating income was GBP 6.1 billion, up 9%.
- +12 more takeaways
Nokia Q4 2025 Earnings Call - Optical and AI-Cloud Demand Driving Growth While Integration and Investment Weigh on Margins
Nokia closed 2025 with steady top-line progress and a clear strategic pivot toward optical and AI-cloud infrastructure. Q4 net sales rose 3% to EUR 6.1 billion, operating profit was EUR 1.0 billion an...
- Q4 2025 results: net sales EUR 6.1 billion (up 3% YoY), operating profit EUR 1.0 billion, free cash flow EUR 226 million.
- Full year 2025: net sales EUR 19.9 billion, operating profit EUR 2.0 billion (slightly above midpoint guidance), free cash flow conversion 72%.
- Strategic repositioning: Nokia completed the Infinera acquisition and reorganized operating segments to focus on Network Infrastructure, Mobile Infrastructure, Portfolio Businesses, Nokia Technologies and Group Common.
- +15 more takeaways